Previous posts on this trial:
↪ Cocoa flavanol extract cut CVD death 27% in the 21,000-person COSMOS trial
↪ COSMOS cocoa extract lowers hsCRP in older adults, possibly explaining CVD benefit
Louis shares a summary of the COSMOS randomized trial of 21,442 older adults taking a 500 mg daily cocoa-extract supplement. It reduced CVD mortality by 27% (HR about 0.73) over 3.6 years as a secondary outcome, without a statistically significant reduction in the primary total CVD events endpoint.
Previous posts on this trial:
↪ Cocoa flavanol extract cut CVD death 27% in the 21,000-person COSMOS trial
↪ COSMOS cocoa extract lowers hsCRP in older adults, possibly explaining CVD benefit
The COSMOS randomized clinical trial of 21,442 older adults found that taking a daily 500 mg cocoa-extract supplement resulted in a 27% reduction in cardiovascular-disease mortality (hazard ratio ≈ 0.73) over 3.6 years, while showing no statistically significant reduction in the primary endpoint of total cardiovascular events; the supplement contained standardized cocoa flavanols, and the mortality reduction was observed as a secondary outcome of the trial.